These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38468530)

  • 1. Drug Design for Alzheimer's Disease: Biologics
    Weaver DF
    Curr Alzheimer Res; 2024; 20(12):821-826. PubMed ID: 38468530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer's disease.
    Wang Z; Wang Y; Pasangulapati JP; Stover KR; Liu X; Schier SW; Weaver DF
    Eur J Med Chem; 2021 Oct; 222():113565. PubMed ID: 34118718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immunopathy of Alzheimer's Disease: Innate or Adaptive?
    Weaver DF
    Curr Alzheimer Res; 2023; 20(2):63-70. PubMed ID: 37198985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
    Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
    Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's Disease, the "One-Molecule, One-Target" Paradigm, and the Multitarget Directed Ligand Approach.
    Oset-Gasque MJ; Marco-Contelles J
    ACS Chem Neurosci; 2018 Mar; 9(3):401-403. PubMed ID: 29465220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress of clinical trials in Alzheimer’s disease drugs].
    Peng Y; Li PP; Li L; Zhang Y; Hou WZ; Cui DD; Li J; Wang L; Wang QL; Wang XL
    Yao Xue Xue Bao; 2016 Aug; 51(8):1185-95. PubMed ID: 29897711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupting beta-amyloid aggregation for Alzheimer disease treatment.
    Estrada LD; Soto C
    Curr Top Med Chem; 2007; 7(1):115-26. PubMed ID: 17266599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014.
    Schneider LS; Mangialasche F; Andreasen N; Feldman H; Giacobini E; Jones R; Mantua V; Mecocci P; Pani L; Winblad B; Kivipelto M
    J Intern Med; 2014 Mar; 275(3):251-83. PubMed ID: 24605808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Molecule Natural Products and Alzheimer's Disease.
    Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z
    Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy in Older Adults with Alzheimer's Disease.
    Esumi S; Ushio S; Zamami Y
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of biological therapies for neurological diseases: moving on from previous failures.
    Qosa H; Volpe DA
    Expert Opin Drug Discov; 2018 Apr; 13(4):283-293. PubMed ID: 29394876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes.
    Silva T; Reis J; Teixeira J; Borges F
    Ageing Res Rev; 2014 May; 15():116-45. PubMed ID: 24726823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tools of the trade: investigations into design strategies of small molecules to target components in Alzheimer's disease.
    Derrick JS; Lim MH
    Chembiochem; 2015 Apr; 16(6):887-98. PubMed ID: 25773481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease.
    Naushad M; Durairajan SSK; Bera AK; Senapati S; Li M
    Planta Med; 2019 Nov; 85(17):1316-1325. PubMed ID: 31618777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer's Disease.
    de Sousa NF; Scotti L; de Moura ÉP; Dos Santos Maia M; Rodrigues GCS; de Medeiros HIR; Lopes SM; Scotti MT
    Curr Neuropharmacol; 2022; 20(5):857-885. PubMed ID: 34636299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Traditional Chinese Medicine Natural Products in β-Amyloid Deposition and Tau Protein Hyperphosphorylation in Alzheimer's Disease.
    Yan H; Feng L; Li M
    Drug Des Devel Ther; 2023; 17():3295-3323. PubMed ID: 38024535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Alzheimer's Disease - Mechanisms, Drug Targets and Alternative Treatments.
    Hua Q; He R
    Curr Top Med Chem; 2016; 16(5):470-1. PubMed ID: 26279184
    [No Abstract]   [Full Text] [Related]  

  • 19. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond.
    Decker M
    Curr Med Chem; 2011; 18(10):1464-75. PubMed ID: 21428895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases.
    Youdim MB; Buccafusco JJ
    J Neural Transm (Vienna); 2005 Apr; 112(4):519-37. PubMed ID: 15666041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.